OLK vs. LNTH, TXG, EYPT, PACB, QTRX, CTKB, LAB, VREX, SEER, and BIO.B
Should you be buying Olink Holding AB (publ) stock or one of its competitors? The main competitors of Olink Holding AB (publ) include Lantheus (LNTH), 10x Genomics (TXG), EyePoint Pharmaceuticals (EYPT), Pacific Biosciences of California (PACB), Quanterix (QTRX), Cytek Biosciences (CTKB), Standard BioTools (LAB), Varex Imaging (VREX), Seer (SEER), and Bio-Rad Laboratories (BIO.B). These companies are all part of the "medical" sector.
Lantheus (NASDAQ:LNTH) and Olink Holding AB (publ) (NASDAQ:OLK) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, community ranking, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.
Lantheus has higher revenue and earnings than Olink Holding AB (publ). Olink Holding AB (publ) is trading at a lower price-to-earnings ratio than Lantheus, indicating that it is currently the more affordable of the two stocks.
Lantheus presently has a consensus price target of $104.14, indicating a potential upside of 67.32%. Olink Holding AB (publ) has a consensus price target of $26.00, indicating a potential upside of 10.59%. Given Olink Holding AB (publ)'s stronger consensus rating and higher possible upside, equities analysts clearly believe Lantheus is more favorable than Olink Holding AB (publ).
99.1% of Lantheus shares are owned by institutional investors. Comparatively, 30.2% of Olink Holding AB (publ) shares are owned by institutional investors. 1.5% of Lantheus shares are owned by company insiders. Comparatively, 5.2% of Olink Holding AB (publ) shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Lantheus received 313 more outperform votes than Olink Holding AB (publ) when rated by MarketBeat users. Likewise, 65.13% of users gave Lantheus an outperform vote while only 34.29% of users gave Olink Holding AB (publ) an outperform vote.
Lantheus has a net margin of 25.20% compared to Lantheus' net margin of -18.63%. Olink Holding AB (publ)'s return on equity of 63.16% beat Lantheus' return on equity.
In the previous week, Olink Holding AB (publ) had 14 more articles in the media than Lantheus. MarketBeat recorded 19 mentions for Olink Holding AB (publ) and 5 mentions for Lantheus. Olink Holding AB (publ)'s average media sentiment score of 1.06 beat Lantheus' score of 0.32 indicating that Lantheus is being referred to more favorably in the media.
Lantheus has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, Olink Holding AB (publ) has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500.
Summary
Lantheus beats Olink Holding AB (publ) on 15 of the 18 factors compared between the two stocks.
Get Olink Holding AB (publ) News Delivered to You Automatically
Sign up to receive the latest news and ratings for OLK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OLK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Olink Holding AB (publ) Competitors List
Related Companies and Tools